Respiratory resistance of patients during cardiac stress testing with adenosine: Is dyspnea a sign of bronchospasm?
Tóm tắt
A denosine is widely used for stress-testing in myocardial perfusion imaging. During adenosine infusion, dyspnea is one of the main complaints of patients. The aim of this study was to determine whether dyspnea during adenosine infusion is caused by bronchospasm. Fifty-four patients were enrolled in the study. Seven of these 54 suffered from mild chronic obstructive pulmonary disease (COPD). We continuously measured respiratory resistance (Rrs), using impulse oscillometry. Respiratory resistance was measured before, during, and after a continuous infusion of 140 μg/kg/min adenosine. Sixty-seven percent of patients suffered from dysnea during adenosine infusion. In patients with mild COPD, Rrs was higher compared with other patients (0.48 vs 0.27 kPa/L/s, P<.05). Neither patients with COPD nor those without COPD exhibited a significant increase in Rrs during adenosine infusion. The Rrs of patients with dyspnea was insignificantly lower compared with patients without dyspnea(P=.469). Dyspnea as a side effect of adenosine infusion is not correlated with impaired respiratory resistance in nonasthmatic pattents and in patients with mild COPD. Thus bronchospasm is ruled out as cause of this clinical symptom. Despite the small number of COPD patients enrolled in the study, adenosine infusion might be possible in patients with mild COPD.
Tài liệu tham khảo
Lindner O, Burchert W, Bengel FM, Zimmermann R, Vom Dahl J, Schafer W, et al. Myocardial perfusion scintigraphy in Germany Results of the 2005 query and oureni Natus. Nuklenmedizin 2007;46:49–55.
Leppo JA. Comparison of pharmacologic stress agents. J Nucl Cardiol 1996;3 (Suppl):S22–6.
Miller DD, Labovitz AJ. Dipyridamole and adenosine vasodilator stress for myocardial imaging: vive la difference! J Am Coll Cardiol 1994;23:390–2.
Miller DD. Impact of selective adenosine A2A receptor agonists on cardiac imaging: feeling the lightning, waiting on the thunder. J Am Coll Cardiol 2005;46:2076–8.
Cerqueira MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS. Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol 1994; 23:384–9.
Oostveen E, MacLeod D, Lorino H, Farre R, Hantos Z, Desager K, et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J: 2003;22:1026–41.
Buist AS. Guidelines for the management of chronic obstructive pulmonary disease. Respir Med 2002;96(Suppl C):S11–6.
Balan KK, Critchley M. Is the dyspnea during adenosine cardiac stress test caused by bronchospasm? Am Heart J 2001;142:142–5.
Burki NK, Dale WJ, Lee LY. Intravenous adenosine and dyspnea in humans. J Appl Physiol 2005;98:180–5.
Burki NK, Alam M, Lee LY. The pulmonary effects of intravenous adenosine in asthmatic subjects. Respir Res 2006;7:139.
Reinhold P, Steinbach G, Langenberg A, Lekeux P. Review of respiratory mechanics in anmals. 3. Methodical and physiologic aspects of the use of the impulse oscilloresistometry system (OIS). Berl Munch Tierarzil Wochenschr 1998;111:253–61.
Pasker HG, Schepers R, Clement J, Van de Woestijne KP. Total respiratory impedance measured by means of the forced oscillation technique in subjects with and without respiratory complaints. Eur Respir J 1996;9:131–9.
Schnellbacher F. Lung function tests with simple and advanced oscilloresistometry. Methods, diagnosticc possibilities and practical value for specialists, hospitals, occupational medicine and expert opinion. Schriftenr Zentralbl Arbeitsmed Arbeitsschutz Prophyl Ergonomie 1981;6:1–63.
Friedrich H, Rolke M, Nolte D. Value of non-plethysmmographic methods in determining airway resistance. Pneumologie 1991;45: 991–6.
Cerqueira MD. Advances in pharmacologic agents in imaging: new A2A receptor agonits. Curr Cardiol Rep 2006;8:119–22.
Cerqueira MD. The future of pharmacologic stress: selective A2A adenosine receptor agonits. Am J Cardiol 2004;94:33D-42D.
Gao Z, Li Z, Baker SP, Lasley RD, Meyer S, Elzein E, et al. Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists. J Pharmacol Exp Ther 2001;298:209–18.
Udelson JE, Heller GV, Wackers FJ, Chai A, Hinchman D, Coleman PS, et al. Randomized, controlled dose-ranging study of the selective adenosine A2A receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging. Circulation 2004;109:457–64.
Engelstein ED, Lerman BB, Somers VK, Rea RF. Role of arterial chemoreceptors in mediating the effects of endogenous adenosine on sympathetic nerve activity. Circulation 1994;90:2919–26.